Strongyloidiasis is extremely more frequent in immigrants than in travellers. Clinical presentations do not differ significantly between the two groups, and the most frequent picture is a chronic infection characterized by intermittent, mild, non-specific symptoms. Acute presentation is rare but it has been reported in travellers. Screening of asymptomatic subjects is not generally recommended, while a presumptive treatment with ivermectin might be justified for all travellers and immigrant patients presenting unexplained eosinophilia and/or compatible symptoms, even in case of negative test results. In fact, delayed diagnosis and treatment has life-threatening consequences in patients with conditions predisposing to development of hyperinfection and dissemination.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s11908-012-0248-6 | DOI Listing |
Chest
November 2024
Infectious Diseases Division, Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX. Electronic address:
Trop Med Infect Dis
August 2024
Internal Medicine/Infectious Diseases Department, Vega Baja Hospital-Orihuela, 03314 Alicante, Spain.
Nefrologia (Engl Ed)
August 2024
Servicio de Nefrología, Parc de Salut Mar, Hospital del Mar, Barcelona, Spain; Grupo de Investigación en Nefropatías, Instituto Hospital del Mar de Investigaciones Médicas (IMIM), RD21/0005/0022 (ISCIII MRR RICORS), Barcelona, Spain. Electronic address:
Trop Med Int Health
September 2024
ISGlobal, Barcelona, Spain.
PLoS Negl Trop Dis
July 2024
Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Institute of International Health, Charité Center for Global Health, Berlin, Germany.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!